Related Experiment Videos
Desflurane inhibits platelet function in vitro similar to halothane
1Department of Anaesthesiology, University Hospital, Cologne, Germany. thomas.berlet@uni-koeln.de
European Journal of Anaesthesiology
|December 3, 2003
Summary
The volatile anesthetic desflurane impairs platelet aggregation, similar to halothane, but does not affect alpha-degranulation. This suggests desflurane may impact platelet thromboxane receptor signaling.
Area of Science:
- Anesthesiology
- Hematology
- Pharmacology
Background:
- Volatile anesthetics like desflurane and halothane are commonly used in surgery.
- Platelet activation is crucial for hemostasis and thrombosis.
- Understanding anesthetic effects on platelets is vital for patient safety.
Purpose of the Study:
- To investigate the in vitro effects of desflurane on platelet activation.
- To compare desflurane's effects with those of halothane.
- To elucidate the specific mechanisms of desflurane-induced platelet dysfunction.
Main Methods:
- Platelet-rich plasma was exposed to desflurane, halothane, or air (control).
- Platelets were stimulated with agonists like ADP and collagen.
- Platelet aggregation and CD62P expression (a marker of activation) were measured using Born aggregometry and flow cytometry.
Main Results:
- Both desflurane and halothane significantly reduced platelet aggregation.
- The inhibitory effect on aggregation was more pronounced with desflurane.
- No significant difference in CD62P expression was observed between anesthetic-exposed and control platelets.
Conclusions:
- Desflurane differentially affects platelet activation, impairing aggregation but not alpha-degranulation.
- These findings suggest a mechanism involving impaired thromboxane receptor signaling, similar to halothane.
- Desflurane's impact on platelet function warrants consideration in clinical settings.